These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1718424)
21. Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template. Canard B; Sarfati R; Richardson CC Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11279-84. PubMed ID: 9326600 [TBL] [Abstract][Full Text] [Related]
22. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase. Tan GT; Kinghorn AD; Hughes SH; Pezzuto JM J Biol Chem; 1991 Dec; 266(35):23529-36. PubMed ID: 1721050 [TBL] [Abstract][Full Text] [Related]
23. The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer. Harris D; Lee R; Misra HS; Pandey PK; Pandey VN Biochemistry; 1998 Apr; 37(17):5903-8. PubMed ID: 9558323 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of HIV-1 reverse transcriptase. Termination of processive synthesis on a natural DNA template is influenced by the sequence of the template-primer stem. Abbotts J; Bebenek K; Kunkel TA; Wilson SH J Biol Chem; 1993 May; 268(14):10312-23. PubMed ID: 7683674 [TBL] [Abstract][Full Text] [Related]
25. Crosslinking of substrates occurs exclusively to the p66 subunit of heterodimeric HIV-1 reverse transcriptase. Cheng N; Painter GR; Furman PA Biochem Biophys Res Commun; 1991 Jan; 174(2):785-9. PubMed ID: 1704228 [TBL] [Abstract][Full Text] [Related]
26. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. Tantillo C; Ding J; Jacobo-Molina A; Nanni RG; Boyer PL; Hughes SH; Pauwels R; Andries K; Janssen PA; Arnold E J Mol Biol; 1994 Oct; 243(3):369-87. PubMed ID: 7525966 [TBL] [Abstract][Full Text] [Related]
27. Active site labeling of HIV-1 reverse transcriptase. Sheng N; Dennis D Biochemistry; 1993 May; 32(18):4938-42. PubMed ID: 7683913 [TBL] [Abstract][Full Text] [Related]
28. RNase D, a reported new activity associated with HIV-1 reverse transcriptase, displays the same cleavage specificity as Escherichia coli RNase III. Hostomsky Z; Hudson GO; Rahmati S; Hostomska Z Nucleic Acids Res; 1992 Nov; 20(21):5819-24. PubMed ID: 1280810 [TBL] [Abstract][Full Text] [Related]
29. Affinity modification of human immunodeficiency virus reverse transcriptase and DNA template by photoreactive dCTP analogs. Doronin SV; Dobrikov MI; Buckle M; Roux P; Buc H; Lavrik OI FEBS Lett; 1994 Nov; 354(2):200-2. PubMed ID: 7525354 [TBL] [Abstract][Full Text] [Related]
30. Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3). Barat C; Le Grice SF; Darlix JL Nucleic Acids Res; 1991 Feb; 19(4):751-7. PubMed ID: 1708122 [TBL] [Abstract][Full Text] [Related]
31. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA. Peletskaya EN; Kogon AA; Tuske S; Arnold E; Hughes SH J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861 [TBL] [Abstract][Full Text] [Related]
32. Interaction of tRNALys with the p66/p66 form of HIV-1 reverse transcriptase stimulates DNA polymerase and ribonuclease H activities. Andreola ML; Nevinsky GA; Barr PJ; Sarih-Cottin L; Bordier B; Fournier M; Litvak S; Tarrago-Litvak L J Biol Chem; 1992 Sep; 267(27):19356-62. PubMed ID: 1382072 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNA(Lys). Bordier B; Tarrago-Litvak L; Sallafranque-Andreola ML; Robert D; Tharaud D; Fournier M; Barr PJ; Litvak S; Sarih-Cottin L Nucleic Acids Res; 1990 Feb; 18(3):429-36. PubMed ID: 1689823 [TBL] [Abstract][Full Text] [Related]
34. Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. Ding J; Das K; Hsiou Y; Sarafianos SG; Clark AD; Jacobo-Molina A; Tantillo C; Hughes SH; Arnold E J Mol Biol; 1998 Dec; 284(4):1095-111. PubMed ID: 9837729 [TBL] [Abstract][Full Text] [Related]
35. Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase. Ben-Artzi H; Zeelon E; Gorecki M; Panet A Proc Natl Acad Sci U S A; 1992 Feb; 89(3):927-31. PubMed ID: 1371014 [TBL] [Abstract][Full Text] [Related]
36. DNA synthesis primed by mononucleotides (de novo synthesis) catalyzed by HIV-1 reverse transcriptase: tRNA(Lys,3) activation. Zakharova OD; Tarrago-Litvak L; Fournier M; Litvak S; Nevinsky GA FEBS Lett; 1995 Oct; 373(3):255-8. PubMed ID: 7589477 [TBL] [Abstract][Full Text] [Related]
37. Analysis of the interactions of HIV1 replication primer tRNA(Lys,3) with nucleocapsid protein and reverse transcriptase. Barat C; Schatz O; Le Grice S; Darlix JL J Mol Biol; 1993 May; 231(2):185-90. PubMed ID: 7685391 [TBL] [Abstract][Full Text] [Related]
38. An expanded model of replicating human immunodeficiency virus reverse transcriptase. Wöhrl BM; Tantillo C; Arnold E; Le Grice SF Biochemistry; 1995 Apr; 34(16):5343-56. PubMed ID: 7537089 [TBL] [Abstract][Full Text] [Related]
39. Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer. Ding J; Jacobo-Molina A; Tantillo C; Lu X; Nanni RG; Arnold E J Mol Recognit; 1994 Jun; 7(2):157-61. PubMed ID: 7530020 [TBL] [Abstract][Full Text] [Related]
40. Active site studies of human immunodeficiency virus reverse transcriptase. Mitchell LL; Cooperman BS Biochemistry; 1992 Aug; 31(33):7707-13. PubMed ID: 1380826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]